Tumor cells in bone secrete pre-osteoclast maturing factors, such as parathyroid hormone-related protein, IL-11, and TNF-ɑ, which stimulate osteoblasts to increase RANKL and decrease osteoprotegerin (OPG) production, consequentially leading to bone destruction [49]. The gene discussed is TNFRSF11B; the disease is neoplasm.